| In vivo and in vitro distribution of type 5 and fiber-modified oncolytic adenoviruses in human blood compartments. | |
| | |
MedLine Citation:
|
PMID: 21261555 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Abstract Background. Successful tumor targeting of systemically administered oncolytic adenoviruses may be hindered by interactions with blood components. Materials and methods. Blood distribution of oncolytic adenoviruses featuring type 5 adenovirus fiber, 5/3 capsid chimerism, or RGD-4C in the fiber knob was investigated in vitro and in patients with refractory solid tumors. Results. Virus titers and prevalence in serum of patients increased over the first post-treatment week, suggesting replication. Detection of low virus loads was more sensitive in blood clots than in serum, although viral levels > 500 viral particles/mL did not differ significantly between both sample types. While adenovirus bound to erythrocytes, platelets, granulocytes, and peripheral blood mononuclear cells in vitro, the virus was mainly detectable in erythrocytes and granulocytes in cancer patients. Taken together with a temporary post-treatment decrease in thrombocyte counts, platelet activation by adenovirus and subsequent clearance seem likely to occur in humans. Fiber modifications had limited observed effect on virus distribution in blood cell compartments. Neutrophils, monocytes and cytotoxic T lymphocytes were the major leukocyte subpopulations interacting with adenoviruses. Conclusion. Serum and blood clots are relevant to estimate oncolytic adenovirus replication. Insight into viral interactions with blood cells may contribute to the development of new strategies for tumor delivery. |
| | |
Authors:
|
Sophie Escutenaire; Vincenzo Cerullo; Iulia Diaconu; Laura Ahtiainen; Päivi Hannuksela; Minna Oksanen; Elina Haavisto; Aila Karioja-Kallio; Sirkka-Liisa Holm; Lotta Kangasniemi; Camilla Ribacka; Satu Kauppinen; Timo Joensuu; T Petteri Arstila; Sari Pesonen; Anna Kanerva; Akseli Hemminki |
Related Documents
:
|
1409765 - A drug used in traditional medicine, harpagophytum procumbens: no evidence for nsaid-li... 18401135 - Monitoring and control of the biogas process based on propionate concentration using on... 1310855 - Guinea pig whole blood 5-lipoxygenase assay: utility in the assessment of potential 5-l... 10133135 - Blood ties: accountability for blood quality in new zealand. 8305595 - Size distribution of liposomes by flow field-flow fractionation. 762735 - White blood cell consumption in the microcirculation after a major burn. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-1-25 |
Journal Detail:
|
Title: Annals of medicine Volume: - ISSN: 1365-2060 ISO Abbreviation: - Publication Date: 2011 Jan |
Date Detail:
|
Created Date: 2011-1-25 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8906388 Medline TA: Ann Med Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Cancer Gene Therapy Group, Transplantation Laboratory, Haartman Institute and Finnish Institute of Molecular Medicine, University of Helsinki, Finland. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Using participatory action research in community-based rehabilitation for people with acquired brain...
Next Document: Matrix metalloproteinase-19 expressed in cerebral amyloid angiopathy.